Inflammatory components of adipose tissue as target for treatment of metabolic syndrome

Forum of Nutrition

Volumn 61, Issue , 2009, Pages 95-103

  Yu, Rina ^a   Kim, Chu Sook ^a   Kang, Ji Hye ^a  

^a University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

ADIPOSE TISSUE; ANIMAL; DIET; DIET THERAPY; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; METABOLISM; METHODOLOGY; MOUSE; OBESITY; REVIEW; SPICE;

ADIPOSE TISSUE; ANIMALS; CAPSAICIN; DIET; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; MICE; OBESITY; SPICES;

EID: 67650218498     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000212742     Document Type: Article

References (32)

1. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006;116:1793- 1801.
2. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867.
3. Weisberg S P, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
4. Xu H, Barnes GT, Yang Q, et al: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821-1830.
5. Yu R, Kim CS, Kwon BS, Kawada T: Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue mac-rophage migration and activation in obese mice. Obesity (Silver Spring) 2006;14:1353-1362.
6. Heilbronn LK, Campbell LV: Adipose tissue mac-rophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008;14: 1225-1230.
7. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-864.
8. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-184.
9. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
10. Hotamisligil GS: Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003; 27(suppl 3):S53-S55.
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95: 2409-2415.
12. Uysal KT, Wiesbrock SM, Marino M W, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-614.
13. Senn JJ, Klover PJ, Nowak IA, et al: Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003;278:13740-13746.
14. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE: Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-417.
15. Bastard J P, Jardel C, Bruckert E, et al: Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-3342.
16. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-214.
17. Bruun JM, Lihn AS, Pedersen SB, Richelsen B: Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90: 2282-2289.
18. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145: 2273-2282.
19. Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 2005;25:2062-2068.
20. Yamauchi T, Hara K, Kubota N, et al: Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:243-254.
21. Ahmed M, Bjurholm A, Srinivasan GR, et al: Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul Pept 1995;55:85-102.
22. Marsh D, Dickenson A, Hatch D, Fitzgerald M: Epidural opioid analgesia in infant rats II: responses to carrageenan and capsaicin. Pain 1999;82:33-38.
23. Park JS, Choi MA, Kim BS, Han IS, Kurata T, Yu R: Capsaicin protects against ethanol-induced oxida-tive injury in the gastric mucosa of rats. Life Sci 2000;67:3087-3093.
24. Kim CS, Kawada T, Kim BS, et al: Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal mac-rophages. Cell Signal 2003;15:299-306.
25. Kang JH, Kim CS, Han IS, Kawada T, Yu R: Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adi-pocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett 2007; 581: 4389-4396.
26. Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P: Low dose rosiglitazone exerts an anti-inflammatory effect with an increase in adiponectin independently of free fatty acid (FFA) fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab 2006;91:3553- 3558.
27. Park JY, Kawada T, Han IS, et al: Capsaicin inhibits the production of tumor necrosis factor alpha by LPS-stimulated murine macrophages, RAW 264.7: a PPARgamma ligand-like action as a novel mechanism. FEBS Lett 2004;572:266-270.
28. Tanaka T, Fukunaga Y, Itoh H, et al: Therapeutic potential of thiazolidinediones in activation of per-oxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. Eur J Pharmacol 2005;508:255-265.
29. Woo HM, Kang JH, Kawada T, Yo o H, Sung MK, Yu R: Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macro-phages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci 2007;80:926- 931.
30. Kuroyanagi K, Kang MS, Goto T, et al: Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2008;366:219-225.
31. Hirai S, Kim YI, Goto T, et al: Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and mac-rophages. Life Sci 2007;81:1272-1279.
32. Choe MR, Kang JH, Yoo H, Choe SY, Yang CH, Kom MO, Yu R: Cyanidin and cyanidin-3-O-b-D-glucoside suppress the inflammatory responses of obese adipose tissue by inhibiting the release of chemokines MCP-1 and MRP-2. J Food Sci Nutr 2007;12:148-153.